Laboratorios Farmaceuticos Rovi
Laboratorios Farmaceuticos Rovi SA is a Spanish specialty pharmaceutical and biotechnology enterprise headquartered in Madrid, Spain. The company specializes in the research, development, manufacturing, and marketing of proprietary pharmaceutical products, low molecular weight heparins (such as enoxaparin), and specialized contract development and manufacturing organization (CDMO) services for injectable products and advanced drug delivery systems. Principal revenue is derived through commercial sales of prescription pharmaceutical products and CDMO manufacturing contract fees. Laboratorios Farmaceuticos Rovi SA is publicly listed on the Madrid Stock Exchange.
5 of the funds FundTelligence covers report a position in Laboratorios Farmaceuticos Rovi.
- Legal name
- Laboratorios Farmaceuticos Rovi SA
- Sector
- Health Care
- Country
- Spain
- Funds holding it
- 5
Funds holding Laboratorios Farmaceuticos Rovi
- T. Rowe Price European Smaller Companies Equity — T. Rowe Price · 1.3 % (full portfolio disclosed, September 2026)
- Handelsbanken Infrastruktur och Beredskap — Handelsbanken · 0.07 % (full portfolio disclosed, October 2026)
- Handelsbanken Global SMB Index Criteria — Handelsbanken · 0.02 % (full portfolio disclosed, October 2026)
- KLP AksjeGlobal Small Cap Indeks — KLP · 0.01 % (partially disclosed portfolio, June 2026)
- DNB Global Enhanced Small Cap — DNB · 0.01 % (full portfolio disclosed, September 2026)